<b>Conclusions</b>: This TET2-APOBEC-based enzymatic cfDNA assay enables sensitive, quantitative, sequencing-free methylation detection under gentle conditions, supporting its application in early colorectal cancer screening and routine clinical liquid biopsy workflows. This evidence concerns the gene TET2 and colorectal cancer.